UNDERWRITING AGREEMENT PASSAGE BIO, INC. [•] Shares of Common Stock, par value $0.0001 per share Underwriting AgreementUnderwriting Agreement • January 19th, 2021 • Passage BIO, Inc. • Biological products, (no disgnostic substances) • New York
AMENDMENT No. 2 TO AMENDED AND RESTATED RESEARCH, COLLABORATION AND LICENSE AGREEMENTPassage BIO, Inc. • January 19th, 2021 • Biological products, (no disgnostic substances)
This AMENDMENT No. 2 to the Amended and Restated Research, Collaboration and License Agreement dated May 5, 2020 is entered into as of November 2, 2020 (the “Amendment No. 2 to Restated Agreement Effective Date”) by and between Passage Bio, Inc., a corporation organized under the laws of Delaware (“Passage”) with offices at 2001 Market St, 28th Floor, Philadelphia, PA 19103, and The Trustees of the University of Pennsylvania, a Pennsylvania nonprofit corporation, with offices located at Penn Center for Innovation, 3600 Civic Center Blvd., 9th Floor, Philadelphia, PA 19104 (“Penn”) and amends the Amendment No.1 to the Amended and Restated Agreement dated August 13, 2020, and the Amended and Restated Research Colaboration and License Agreement dated May 5, 2020, as amended by the Amendment No.1 dated August 13, 2020 (the “Restated Agreement”). Passage and Penn are referred to collectively as the “Parties” and individually as a “Party.”
AMENDMENT No. 3 TO AMENDED AND RESTATED RESEARCH, COLLABORATION AND LICENSE AGREEMENTCollaboration and License Agreement • January 19th, 2021 • Passage BIO, Inc. • Biological products, (no disgnostic substances)
This AMENDMENT No. 3 to the Amended and Restated Research, Collaboration and License Agreement dated May 5, 2020 is entered into as of December 9, 2020 (the “Amendment No. 3 to Restated Agreement Effective Date”) by and between Passage Bio, Inc., a corporation organized under the laws of Delaware (“Passage”) with offices at 2001 Market St, 28th Floor, Philadelphia, PA 19103, and The Trustees of the University of Pennsylvania, a Pennsylvania nonprofit corporation, with offices located at Penn Center for Innovation, 3600 Civic Center Blvd., 9th Floor, Philadelphia, PA 19104 (“Penn”) and amends the Amended and Restated Research Collaboration and License Agreement dated May 5, 2020, as amended by the Amendment No.1 dated August 13, 2020 and Amendment No. 2 dated November 2, 2020 (the “Restated Agreement”). Passage and Penn are referred to collectively as the “Parties” and individually as a “Party.”
